BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
CranioSense
/
Gordon Hirschman
GH
Gordon Hirschman
COB & Co-Founder
CranioSense
Therapeutic Areas
Traumatic Brain Injury
Neurology
CranioSense Pipeline
Drug
Indication
Phase
IPASS
Non-invasive measurement of Intracranial Pressure (ICP)
Pilot Validation
Leadership Team at CranioSense
RM
Ryan Myers, PhD
CEO & Co-Founder
KD
Kristian DiMatteo
COO & Co-Founder
View full CranioSense profile